Westlake Chemical Partners LP () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

49.23 k

Shareholding (Mar 2025)

FII

1.26%

Held by 6 FIIs

DII

71.45%

Held by 28 DIIs

Promoter

0.36%

How big is Westlake Chemical Partners LP?

22-Jun-2025

As of Jun 18, Westlake Chemical Partners LP has a market capitalization of 778.07 million, with net sales of 1,088.86 million and a net profit of 321.83 million over the latest four quarters.

What does Westlake Chemical Partners LP do?

22-Jun-2025

Westlake Chemical Partners LP is a micro-cap company in the specialty chemicals industry, reporting net sales of $238 million and a net profit of $42 million as of March 2025. Key financial metrics include a P/E ratio of 2.00 and a return on equity of 63.47%.

Is Westlake Chemical Partners LP technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, Westlake Chemical Partners LP is in a bearish trend with weak strength indicators, as shown by the MACD and Bollinger Bands, and has underperformed the S&P 500 with a year-to-date return of -7.22%.

Is Westlake Chemical Partners LP overvalued or undervalued?

05-Nov-2025

As of October 31, 2025, Westlake Chemical Partners LP is considered undervalued with an attractive valuation grade, a low P/E ratio of 2 compared to peers, strong performance metrics like a 63.47% ROE, and a potential buying opportunity despite a year-to-date stock underperformance of -20.05% relative to the S&P 500's 16.30% return.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROCE of 41.50%

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.74 times

Poor long term growth as Operating profit has grown by an annual rate -1.43% of over the last 5 years

The company declared very negative results in Mar'25 after flat results in Dec'24

With ROCE of 39.90%, it has a very attractive valuation with a 1.32 Enterprise value to Capital Employed

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

USD 774 Million (Micro Cap)

P/E

2.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.72

Return on Equity

63.29%

Price to Book

1.53

Revenue and Profits:

Net Sales:

297 Million

(Quarterly Results - Jun 2025)

Net Profit:

86 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-13.36%

6 Months

-14.65%

1 Year

-20.46%

2 Years

-13.48%

3 Years

-18.23%

4 Years

-19.38%

5 Years

-14.11%

Westlake Chemical Partners LP for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Westlake Chemical Partners LP overvalued or undervalued?

As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears undervalued, with a P/E ratio of 2, significantly lower than its peers such as Kronos Worldwide, Inc. with a P/E of 10.01, and Advansix, Inc. at 8.36. Additionally, Westlake's EV to EBITDA ratio stands at 2.50, which is competitive compared to the industry average, suggesting potential for growth. In terms of performance metrics, Westlake boasts a robust ROE of 63.47% and an impressive ROCE of 39.90%, highlighting its efficient use of equity and capital. However, the company's stock has underperformed relative to the S&P 500, with a year-to-date return of -20.05% compared to the index's 16.30%. This disparity reinforces the notion that the stock may be undervalued, presenting a potential buying opportunity for investors....

Is Westlake Chemical Partners LP overvalued or undervalued?

As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP moved from fair to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, with a P/E ratio of 2, significantly lower than its peers, such as Kronos Worldwide, Inc. at 10.01 and Advansix, Inc. at 8.36. Additionally, Westlake's EV to EBITDA stands at 2.50, while the industry average is considerably higher, further supporting the undervaluation thesis. In terms of performance, Westlake Chemical has underperformed relative to the S&P 500 across multiple periods, with a year-to-date return of -19.32% compared to the S&P 500's 16.30%. This trend continues over one year and three years, where Westlake's returns of -16.47% and -20.32% starkly contrast with the S&P 500's 19.89% and 76.66%, respectively. Overall, the combination of low valuation ratios and poor stock performance relative to the ...

Is Westlake Chemical Partners LP overvalued or undervalued?

As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP moved from fair to attractive, indicating a more favorable assessment of its worth. The company appears undervalued, supported by a low P/E ratio of 2, a price-to-book value of 1.54, and an EV to EBITDA ratio of 2.50. In comparison to peers, Westlake's P/E ratio is significantly lower than that of Kronos Worldwide, Inc. at 10.01 and Advansix, Inc. at 8.36, reinforcing the notion of undervaluation. Despite the attractive valuation metrics, Westlake has underperformed against the S&P 500, with a year-to-date return of -18.50% compared to the index's 16.30%. This underperformance over multiple periods suggests that while the company may be undervalued based on its financial ratios, market sentiment has not yet aligned with its intrinsic value....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1.73%

EBIT Growth (5y)

-1.43%

EBIT to Interest (avg)

25.44

Debt to EBITDA (avg)

0.74

Net Debt to Equity (avg)

0.69

Sales to Capital Employed (avg)

1.32

Tax Ratio

0.23%

Dividend Payout Ratio

106.48%

Pledged Shares

Institutional Holding

31.69%

ROCE (avg)

41.50%

ROE (avg)

66.20%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.54

EV to EBIT

3.31

EV to EBITDA

2.50

EV to Capital Employed

1.32

EV to Sales

1.04

PEG Ratio

Dividend Yield

ROCE (Latest)

39.90%

ROE (Latest)

63.47%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 7 Schemes (26.92%)

Foreign Institutions

Held by 6 Foreign Institutions (1.26%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 25.04% vs -18.10% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 102.84% vs -51.60% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "297.10",
          "val2": "237.60",
          "chgp": "25.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "123.70",
          "val2": "73.70",
          "chgp": "67.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.90",
          "val2": "5.50",
          "chgp": "7.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "85.80",
          "val2": "42.30",
          "chgp": "102.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "307.10%",
          "val2": "196.10%",
          "chgp": "11.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -4.61% vs -25.25% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.34% vs -0.06% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,135.90",
          "val2": "1,190.80",
          "chgp": "-4.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "502.30",
          "val2": "467.90",
          "chgp": "7.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "25.70",
          "val2": "26.50",
          "chgp": "-3.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "369.20",
          "val2": "334.60",
          "chgp": "10.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "343.70%",
          "val2": "300.40%",
          "chgp": "4.33%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

297.10

237.60

25.04%

Operating Profit (PBDIT) excl Other Income

123.70

73.70

67.84%

Interest

5.90

5.50

7.27%

Exceptional Items

0.00

Consolidate Net Profit

85.80

42.30

102.84%

Operating Profit Margin (Excl OI)

307.10%

196.10%

11.10%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 25.04% vs -18.10% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 102.84% vs -51.60% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,135.90

1,190.80

-4.61%

Operating Profit (PBDIT) excl Other Income

502.30

467.90

7.35%

Interest

25.70

26.50

-3.02%

Exceptional Items

0.00

Consolidate Net Profit

369.20

334.60

10.34%

Operating Profit Margin (Excl OI)

343.70%

300.40%

4.33%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -4.61% vs -25.25% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 10.34% vs -0.06% in Dec 2023

All Annual Results

Company CV

About Westlake Chemical Partners LP

Westlake Chemical Partners LP

Specialty Chemicals

No Details Available.

Company Coordinates

No Company Details Available

Westlake Chemical Partners LP

1Day

52 Week

CASH

FII

DII

Promoter

How big is Westlake Chemical Partners LP?

Watch in Real-Time

What does Westlake Chemical Partners LP do?

Is Westlake Chemical Partners LP technically bullish or bearish?

Is Westlake Chemical Partners LP overvalued or undervalued?

MarketsMojo — Loved in India, Now Global

Dashboard

High Management Efficiency with a high ROCE of 41.50%

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.74 times

Poor long term growth as Operating profit has grown by an annual rate -1.43% of over the last 5 years

The company declared very negative results in Mar'25 after flat results in Dec'24

With ROCE of 39.90%, it has a very attractive valuation with a 1.32 Enterprise value to Capital Employed

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Westlake Chemical Partners LP overvalued or undervalued?

Is Westlake Chemical Partners LP overvalued or undervalued?

Is Westlake Chemical Partners LP overvalued or undervalued?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Westlake Chemical Partners LP

Company Coordinates